This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Coagulation Analyzers Market

Coagulation Analyzers Market By Product (Stains, Analyzers, Reagents, Clinical Laboratory Analyzers, Consumables, Point of Care Analyzers), Technology (Nephelometric, Mechanical, Photo-optical/Chromogenic/Immuno, Optical, Electrochemical), Test Type (Prothrombin, Fibrinogen, D-Dimer, APTT) & Region - Forecast 2022-2032

Market Insights on Coagulation Analyzers covering sales outlook, demand forecast & up-to-date key trends

Coagulation Analyzers Market Overview

The global coagulation analyzers market size is expected to be valued at US$ 7.8 Billion in 2032 and exhibit growth at a CAGR of 11.3% in the forecast period from 2022 to 2032. It is expected to grow at a steady pace and reach US$ 5.1 Billion in 2022. The rising prevalence of blood disorders and cardiovascular diseases among the geriatric population is projected to spur the sales of coagulation analyzers in the assessment period.

Report Attribute

Details

Coagulation Analyzers Market Estimated Base Year Value (2021)

US$ 4.0 Billion

Coagulation Analyzers Market Expected Value (2022)

US$ 5.1 Billion

Coagulation Analyzers Market Anticipated Forecast Value (2032)

US$ 7.8 Billion

Coagulation Analyzers Market Projected Growth Rate (2022-2032)

11.3% CAGR

Coagulation analyzers are advanced blood inspecting and analyzing instruments. The increasing focus of governments of various countries on healthcare research activities owing to the sudden outbreak of the COVID-19 pandemic in December 2019 is expected to fuel the coagulation analyzers market growth.

The increasing smoking habit, obesity, hereditary factors, and deficiency of vitamin K are anticipated to result in the rising cases of blood clotting disorders among people worldwide. Hence, the urgent need to efficiently detect blood clots is set to drive the demand for analyzers.

In October 2021, for instance, Trivitron Healthcare, a leading medical devices company based in Chennai, unveiled its latest range of coagulation analyzer products in India. These were manufactured in collaboration with Diagon-Vanguard Diagnostics. These new products can check the efficacy of anti-coagulant drugs and hemostatic therapies, as well as lower the risk of bleeding in extensive surgeries. Thus, the ongoing launch of technologically advanced products by key players globally is a vital factor propelling the growth.

Which are Some Prominent Drivers Spearheading Coagulation Analyzers Market Growth?

The demand for coagulation analyzers is anticipated to surge in the forthcoming years worldwide backed by the rising cases of chronic blood disorders and lifestyle associated diseases. The increasing awareness about these disorders among people to enhance preventive care management and diagnostic rate is another significant factor that is expected to augur well for the global market.

The growing usage of prothrombin time tests for measuring the total time taken for the blood to clot in healthcare facilities is set to drive the market. These are estimated to be extensively used in hospitals for monitoring patients implanted with ventricular assist devices or mechanical heart valves. The rising number of patients suffering from pulmonary embolism, chronic atrial fibrillation, deep venous thrombosis, and venous embolism is also likely to propel the market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Coagulation Analyzers Industry?

Coagulation analyzers cannot generate comments on red cell morphology. These are also incapable of recognizing abnormal red cell shapes, especially fragmented cells. The newly launched cutting-edge analyzers are expensive and require high running costs, which may not be affordable for start-up companies. On the other hand, flagging can occur in between tests, which would require labor-intensive examination of blood. Spurred by the above-mentioned factors, the sales of coagulation analyzers may decline in the future years.

Why is North America emerging as an Opportunistic Coagulation Analyzers Market?

North America is expected to remain at the forefront in the evaluation period in terms of the coagulation analyzers market share. The presence of favorable healthcare resources and government norms associated with the medical industry are set to bode well for the market.

In addition, the rising prevalence of various cardiometabolic disorders, such as Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) is another crucial factor that is projected to boost the North America market. As per the Centers for Disease Control and Prevention (CDC), nearly 60,000 to 100,000 people die of DVT/PE in the U.S. every year. Sudden death is the first symptom of PE in about 25% of people. These numbers are likely to grow in the upcoming years, thereby bolstering the market in this region.

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Asia Pacific Contributing to Growth of the Coagulation Analyzers Market?

The increasing number of clinics, hospitals, and health centers in developing countries, such as India and China is anticipated to fuel the Asia Pacific coagulation analyzers market growth. The presence of skilled healthcare staff equipped to deliver effective and safe treatment in these countries is another factor that is set to augment the market.

The surging geriatric population affected by leukemia, sickle-cell anemia, and thalassemia is estimated to push the sales in Asia Pacific. Researchers at the Guangxi Medical University, for instance, found that the prevalence of thalassemia was the highest in South China. Thus, the increasing number of research and development activities conducted by numerous educational and research institutions is projected to propel the Asia Pacific market.

Market Competition

Some of the renowned players operating in the global coagulation analyzers market include Beijing Succeeder Technology Inc., Abbott Laboratories, Genrui Biotech Inc., Danaher, Maccura Biotechnology Co. Ltd., Helena Laboratories, ERBA Diagnostics, Inc., Siemens Healthineers Group, Hycel, Haematonics, Nihon Kohden, Bpc Biosed Srl, Sysmex Group, Robimes India Pvt. Ltd., Eurolyser, Biosystems S.A., Thermo Fisher Scientific, Diagnostica Stago SAS, Roche Diagnostics, ACON, Horiba, Meril Life Sciences, A&T Corporation, Bio Group Medical System, and Sclavo Diagnostics International S.r.l among others.

Majority of the leading players are present in the international space and are competing directly to generate more sales owing to their easy global accessibility. They are extensively utilizing third party vendors to distribute their products across the globe. Meanwhile, a few other key players are investing huge sums for the development of their distribution offices in various parts of the world.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 11.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product
  • Technology
  • Test Type
  • End Use
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Easter Europe
  • APEJ
  • Japan
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Beijing Succeeder Technology Inc.
  • Abbott Laboratories
  • Genrui Biotech Inc.
  • Danaher
  • Maccura Biotechnology Co. Ltd.
  • Helena Laboratories
  • ERBA Diagnostics, Inc.
  • Siemens Healthineers Group
  • Hycel
  • Haematonics
  • Nihon Kohden
  • Bpc Biosed Srl
  • Sysmex Group
  • Robimes India Pvt. Ltd.
  • Eurolyser
  • Biosystems S.A.
  • Thermo Fisher Scientific
  • Diagnostica Stago SAS
  • Roche Diagnostics
  • ACON
  • Horiba
  • Meril Life Sciences
  • A&T Corporation
  • Bio Group Medical System
  • Sclavo Diagnostics International S.r.l

Customization

Available Upon Request

Key Segments Profiled in the Coagulation Analyzers Industry Survey

By Product:

  • Stains
  • Analyzers
  • Reagents
  • Clinical Laboratory Analyzers
  • Consumables
  • Point of Care Analyzers

By Technology:

  • Nephelometric
  • Mechanical
  • Photo-optical/Chromogenic/Immuno
  • Optical
  • Electrochemical

By Test Type:

  • Prothrombin
  • Fibrinogen
  • D-Dimer
  • APTT

By End Use:

  • Diagnostic Centers
  • Research Institutes
  • Hospitals

By Region:

  • North America
  • Latin America
  • Western Europe
  • Easter Europe
  • APEJ
  • Japan
  • Middle East & Africa

Frequently Asked Questions

The global coagulation analyzers market is estimated to showcase a considerable CAGR of 11.3% by 2032.

North America is set to lead the coagulation analyzers market in terms of share.

Beijing Succeeder Technology Inc., Abbott Laboratories, Genrui Biotech Inc., Danaher, Maccura Biotechnology Co. Ltd., and Helena Laboratories are some of the reputed manufacturers of coagulation analyzers.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Testing Equipment Insights

View Reports
Google translate

Coagulation Analyzers Market